{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-003071","form_type":"8-K","ticker":"PIII","cik":"0001832511","company_name":"P3 Health Partners Inc.","filed_at":"2023-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.928927+00:00","generated_at":"2026-06-20T16:39:55.721376+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"P3 Health reaffirms 2022 guidance, sees 2023 revenue $1.2B-$1.25B, narrower EBITDA loss","bullets":["Reaffirmed FY2022 revenue $1.025B-$1.075B (61-69% YoY growth); at-risk MA membership >100k.","FY2023 guidance: revenue $1.20B-$1.25B, membership 115k-120k, Adj. EBITDA loss $40M-$60M.","Company anticipates achieving positive Adj. EBITDA in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-003071","json":"https://secwatch.observer/filing/0001104659-23-003071.json","markdown":"https://secwatch.observer/filing/0001104659-23-003071.md","text":"https://secwatch.observer/filing/0001104659-23-003071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/0001104659-23-003071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/tm233132d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T16:39:55.721376+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"790b7cb8928bdba17fdf75432bc377b252ad2d47","claim":"P3 Health Partners Inc. updated its full-year 2022 guidance (reaffirmed).","evidence_excerpt":"P3 is reaffirming full-year 2022 financial guidance","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/0001104659-23-003071-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full-year 2022"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"790b7cb8928bdba17fdf75432bc377b252ad2d47","claim":"P3 Health Partners Inc. updated its full-year 2022 guidance (reaffirmed).","evidence_excerpt":"P3 is reaffirming the revenue guidance range given on the third quarter earnings call of between $1.025 billion and $1.075 billion","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/0001104659-23-003071-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full-year 2022"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"c8f36de5f7dd7a041ebe8f711e80fe974e53fc41","claim":"P3 Health Partners Inc. updated its full-year 2023 guidance (initiated).","evidence_excerpt":"announcing financial guidance for the full-year 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/0001104659-23-003071-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full-year 2023"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"c8f36de5f7dd7a041ebe8f711e80fe974e53fc41","claim":"P3 Health Partners Inc. updated its full-year 2023 guidance (initiated).","evidence_excerpt":"Revenue is expected to be in a range of $1.20 billion to $1.25 billion","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/0001104659-23-003071-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full-year 2023"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}